Related Experiment Video

Updated: Sep 10, 2025

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

15.9K

HLA Vaccine Effect in Double Cord Blood Transplant: Chinese Cohort

Chi Hang Wong1, Wilson Yau Ki Chan1, Pamela Pui Wah Lee2

  • 1Hong Kong Children's Hospital, Hong Kong, Hong Kong.

Blood Advances
|August 19, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.9K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K

Related Experiment Videos

Last Updated: Sep 10, 2025

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

15.9K
Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus
11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

12.9K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

2.4K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495

Articles linked to this work by shared authors, journal, and citation graph.

A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

Blood cancer discovery·2026

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

Trials·2026

Quadruple immunotherapy with allogeneic natural killer cell infusion for recurrent neuroblastoma.

Cytotherapy·2026

Generation of CCR4/CD7 Bispecific CAR-T Cells Resistant to Fratricide and Exhaustion.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

High infection rates and risk-adapted prevention strategies in contemporary pediatric allogeneic hematopoietic stem cell transplantation.

Pediatric discovery·2025

Novel CD62L depleted donor lymphocyte infusion with T-cell receptor alpha-beta depleted haploidentical hematopoietic stem cell transplantation in children.

Transplant immunology·2025

Phase 1, open-label, multicenter study of sovleplenib (HMPL-523) in patients with relapsed or refractory lymphoma.

Blood advances·2026

Induction intensity in transplant-eligible primary CNS lymphoma: no survival benefit despite increased toxicity.

Blood advances·2026

Grip strength is associated with overall survival in myelodysplastic syndrome.

Blood advances·2026

Advancing mortality risk prediction in sickle cell disease through multi-task deep learning models.

Blood advances·2026

A CRISPR-Based Humanized Model Reveals Cooperative Role of STAG2 Loss in Familial GATA2-Deficient MDS Progression.

Blood advances·2026

Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas.

Blood advances·2026

Associations Between Patient Language Preference and Hepatitis C Screening: Results From the DETECT Hep C Emergency Department Screening Trial.

Annals of emergency medicine·2026

A Robust Educational Initiative for EMS Clinicians Focusing on Pit-Crew CPR Improves Neurologically Intact Survival.

Prehospital emergency care·2026

Primary and secondary prevention of cervical cancer during the COVID-19 pandemic in Sao Paulo State, Brazil.

Revista do Instituto de Medicina Tropical de Sao Paulo·2026

Impact of Health Promotion Programs on Incarcerated Individuals in Northern Mexico.

International journal of preventive medicine·2026

Ripple Effects Mapping of a gender equity and social inclusion behaviour change activity in Uganda's trachoma effort.

International health·2026

Effectiveness of community-based PrEP delivery for men who have sex with men: a global systematic review and meta-analysis.

Frontiers in public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us